AI Articles and Analysis in Healthcare

Tute Genomics is part of a grand shift towards the leveraging of genetic information towards better health and better treatments. One of the "holy grails" of this transition from one to the other is the advent of

If getting funding was easy, it wouldn't be called "getting funding."

Prospero Biosciences CEO Jonathan Rodriguez came on for an interview at Emerj to talk about his company and technology, as well as to shed some light on the real world experiences that a Biotech founder will face.